Hiroshi Gomyo
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 10
- Oncology 8
- Viral-associated cancers and disorders 8
- Co-authors
- Shigeo Nakamura (3 shared papers)Tohru Murayama (9 shared papers)Keisei Kawa (1 shared paper)Kenzo Takada (1 shared paper)Kazuo Oshimi (1 shared paper)Ritsuro Suzuki (1 shared paper)Rie Hyo (1 shared paper)Masataka Okamoto (1 shared paper)
- Journals
- Blood (4 papers)Journal of Clinical and Experimental Hematopathology (2 papers)Bone Marrow Transplantation (1 paper)American Journal of Hematology (1 paper)Haematologica (1 paper)
- Partner nations
- Japan
In The Last Decade
Hiroshi Gomyo
19 papers receiving 381 citations
Peers
Comparison fields: 5 of 52
- Pathology and Forensic Medicine 233
- Oncology 207
- Hematology 79
- Immunology 126
- Genetics 47
Countries citing papers authored by Hiroshi Gomyo
This map shows the geographic impact of Hiroshi Gomyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Gomyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Gomyo more than expected).
Fields of papers citing papers by Hiroshi Gomyo
This network shows the impact of papers produced by Hiroshi Gomyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Gomyo. The network helps show where Hiroshi Gomyo may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Gomyo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 144 | |
| 2 | 2000 | 36 | |
| 3 | 2002 | 30 | |
| 4 | 2017 | 29 | |
| 5 | 2007 | 27 | |
| 6 | Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease. | 2000 | 23 |
| 7 | Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma. | 2003 | 19 |
| 8 | 2004 | 15 | |
| 9 | 2003 | 10 | |
| 10 | 2016 | 9 | |
| 11 | 2007 | 8 | |
| 12 | 2000 | 7 | |
| 13 | 2010 | 7 | |
| 14 | 2004 | 6 | |
| 15 | 2018 | 6 | |
| 16 | 2003 | 4 | |
| 17 | 2015 | 3 | |
| 18 | 2005 | 2 | |
| 19 | [Invasive pulmonary aspergillosis complicated by complete atrioventricular block and aspergillus pericarditis after induction chemotherapy in a patient with acute lymphoblastic leukemia]. | 2003 | 1 |
About Hiroshi Gomyo
Hiroshi Gomyo is a scholar working on Pathology and Forensic Medicine, Oncology, Hematology, Genetics and Immunology, having authored 19 papers that have together received 386 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Viral-associated cancers and disorders (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), Acute Myeloid Leukemia Research (4 papers), Immune Cell Function and Interaction (3 papers), Hematopoietic Stem Cell Transplantation (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers) and Genomic variations and chromosomal abnormalities (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (233 citations), Oncology (207 citations), Hematology (79 citations), Immunology (126 citations) and Genetics (47 citations). Hiroshi Gomyo has collaborated with scholars based in Japan. Frequent co-authors include Shigeo Nakamura, Tohru Murayama, Keisei Kawa, Kenzo Takada, Kazuo Oshimi, Ritsuro Suzuki, Rie Hyo, Masataka Okamoto, Junji Suzumiya and Tadashi Koike. Their work appears in journals such as Blood, Journal of Clinical and Experimental Hematopathology, Bone Marrow Transplantation, American Journal of Hematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.